ACCOUNT

Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search

SECTIONS

HOME
- Homepage
- This Just In
- Chats
- Weather
- Traffic
- Event Guide
- PG Store
- PGe
- Video
- Photos
- The Digs
- RSS Feeds
NEWS
- News Home
- COVID-19
- World
- Nation
- State
- Obituaries
- News Obituaries
- Politics
- Education
- Portfolio
- Science
- Health & Wellness
- Environment
- Aging Edge
- Transportation
- Faith & Religion
- Crimes & Courts
- Social Services
LOCAL
- Local Home
- Region
- City
- North
- East
- West
- South
- Washington
- Westmoreland
- The Neighborhood
- Obituaries
- Classifieds
- Legal Notices
- Real Estate
SPORTS
- Sports Home
- Steelers
- Penguins
- Pirates
- Sports Columns
- Gene Collier
- Ron Cook
- Joe Starkey
- Paul Zeise
- High School Sports
- College Sports
- Pitt
- Penn State
- WVU
- NCAA
- NFL
- MLB
- NBA
- NHL
- North Shore Drive Podcast
OPINION
A&E
- A&E Home
- Celebrities
- Movies
- TV & Radio
- Music
- Concert Listings
- Theatre & Dance
- Art & Architecture
- Books
- Events
LIFE
- Life Home
- Food
- Buying Here
- Homes & Gardens
- Style & Fashion
- Travel
- Restaurants
- Seen
- goodness
- Random Acts of Kindness
- Pets
- Beer Me
- Outdoors
- Holidays
BUSINESS

OTHER

PGe
NEWSLETTERS
PG STORE
ARCHIVES

CLASSIFIEDS

OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS

CONTACT US
ADVERTISING
CAREER OPPORTUNITIES

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by United Therapeutics Corporation

< Previous 1 2 3 Next >

United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025

October 15, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting

October 13, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis

September 19, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum

September 16, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress

September 12, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis

September 02, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

August 29, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program

August 01, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results

July 30, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025

July 16, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

June 24, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension

June 23, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

April 30, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference

April 21, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025

April 16, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific Sessions

April 04, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to Work

April 02, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the Leerink Partners Global Healthcare Conference 2025

March 04, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial Results

February 26, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference

February 24, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025

February 19, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis

February 04, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical Trial

February 03, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual Congress

January 21, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference

January 06, 2025

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Announces Successful World’s First UKidney Transplant

December 17, 2024

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Present at the UBS Global Healthcare Conference

November 05, 2024

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Reports Third Quarter 2024 Financial Results

October 30, 2024

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion Service

October 23, 2024

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

United Therapeutics Corporation to Report Third Quarter 2024 Financial Results Before the Market Opens on Wednesday, October 30, 2024

October 23, 2024

From United Therapeutics Corporation

Via Business Wire

Tickers UTHR

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.